Pediatr Gastroenterol Hepatol Nutr.  2022 Jul;25(4):293-299. 10.5223/pghn.2022.25.4.293.

Clinical Features of Eosinophilic Esophagitis: A Single Center Experience in Ecuador

• Muñoz FV
• Almeida PH
• Carrión-Jaramillo E
• Montalvo AV

• KMID: 2531165
• DOI: http://doi.org/10.5223/pghn.2022.25.4.293

Abstract

Purpose
Data on eosinophilic esophagitis (EoE) in South America is scarce. Moreover, no studies are available in Ecuador. We evaluated the clinical, endoscopic, and histological characteristics of Ecuadorian children with EoE.
Methods
Medical records of 2,711 children who underwent upper gastrointestinal endoscopy (UGE) between 2009 and 2020 at Hospital Metropolitano de Quito, Ecuador were reviewed. Esophageal mucosal biopsies were obtained from 72 patients and the features of 35 children with EoE were described. EoE was diagnosed when there were more than 15 eosinophils in the esophagus, per high power field.
Results
EoE was diagnosed in 35 children (9.4±4.5 years) with a male predominance (74%). Abdominal pain (51.4%) and vomiting (31.4%) were dominant symptoms. A history of allergic diseases was noted in 47.1% of the children, which mainly included allergic rhinitis (37.1%) and atopic dermatitis (11.4%). The most common endoscopic findings were furrowing (82.9%) and edema (74.3%). All patients were initially treated with proton-pump inhibitors (PPIs). Those who did not respond to PPIs received steroids (5.7%) and diet therapy (5.7%), and five patients were referred to an allergist. Clinical and histological resolution was observed in 65% of the patients who underwent a second UGE after 6–8 weeks of PPI.
Conclusion
Our study describes the clinical features of pediatric EoE in Ecuador. This is the first retrospective study in Ecuador that describes the clinical, endoscopic, and histological manifestations of EoE in a small pediatric population. Almost half of the children who underwent a biopsy had EoE.

Keyword

Eosinophilic esophagitis; Pediatrics; Proton pump inhibitors